Skip to content

A study to evaluate the effect of multi-supplement intake on attenuating fatigue sensation

A study to evaluate the effect of multi-supplement intake on attenuating fatigue sensation - The effect of multi-supplement intake on attenuating fatigue sensation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000023757
Enrollment
20
Registered
2018-05-14
Start date
2016-08-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Sponsors

Soiken Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Healthy males and females aged from 30 to 60 years (bounds included) 2) Subject whose total score of Chalder Fatigue Scale is 21 or more 3) Subject having a briefing of the content of the present study, fully understanding and agreeing to its objective and being able to personally sign a written informed consent

Exclusion criteria

Exclusion criteria: 1) Subject receiving a medical treatment for serious renal, hepatic, cardio-vascular, respiratory, endocrine or metabolic disorders or having a medical history of these disorders 2) Subject having the chronic fatigue syndrome (CFS), or subject deemed to have severe fatigue like idiopathic chronic fatigue by the investigator 3) Subject having food allergy (gelatin) 4) Subject having a medical history of chest pain or syncope 5) Subject having an abnormality in the electrocardiogram 6) Subject having a subjective symptom of low back pain, arthralgia or lumbar hernia, disease of lower limbs, palpitations 7) Subject who regularly takes medicine or quasi-drugs having the efficacy on recovery of fatigue or nutrition disorder at physical fatigue 8) Subject who regularly takes processed food containing ingredients known to attenuate fatigue sensation 9) Subject who regularly takes food containing large amounts of carotenoid 10) Subject having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) 11) Subject who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study 12) Female subject who is pregnant or lactating, or intending to become pregnant during the study 13) Subject deemed unsuitable by the investigator

Design outcomes

Primary

MeasureTime frame
Visual analogue scale (VAS), Chalder Fatigue Scale

Secondary

MeasureTime frame
Advanced trail making test (ATMT), 10-second high power test, spectrum analysis a-a interval of accelerated plethysmography, POMS 2 Adult Short, OSA sleep inventory MA version, oxidative stress markers, safety evaluation

Countries

Japan

Contacts

Public ContactTomohiro Sugino

Soiken Inc. R&D Division

sugino@soiken.com06-6871-8888

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026